Trials / Completed
CompletedNCT01486836
Lumax DX / Linox DX Evaluation
Evaluation of the Lumax DX ICD and the Linox DX Lead (ICD=Implantable Cardioverter Defibrillator, DX=Extended Diagnostics)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 38 (estimated)
- Sponsor
- Biotronik SE & Co. KG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to investigate the safety and efficacy of the Lumax DX / Linox DX system. No hypothesis has been defined.
Conditions
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2011-12-07
- Last updated
- 2013-09-12
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01486836. Inclusion in this directory is not an endorsement.